We are live on
!
Find out more
B
Baird Portfolio holdings
AUM
$9.78B
1-Year Est. Return
11.39%
This Fund
S&P 500
This Quarter
Est. Return
+3.95%
1 Year Est. Return
+11.39%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.13B
AUM Growth
+$230M
(+3.3%)
Cap. Flow
-$15.6M
Cap. Flow
% of AUM
-0.22%
Top 10 Holdings %
Top 10 Hldgs %
13.37%
Holding
1,232
New
125
Increased
506
Reduced
470
Closed
92
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
International Paper
IP
|
+$40.8M |
| 2 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$27.1M |
| 3 |
DFS
Discover Financial Services
DFS
|
+$26.8M |
| 4 |
Globus Medical
GMED
|
+$20.2M |
| 5 |
AWAY
HOMEAWAY INC COM
AWAY
|
+$19.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Toronto Dominion Bank
TD
|
+$42.2M |
| 2 |
Deere & Co
DE
|
+$37.3M |
| 3 |
iShares Russell 2000 Growth ETF
IWO
|
+$29.6M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$25.9M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$24.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 12.96% |
| 2 | Technology | 11.17% |
| 3 | Healthcare | 10.42% |
| 4 | Financials | 10.28% |
| 5 | Consumer Discretionary | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Warner Bros
WBD
$65.2B
| $1.87M | 0.03% |
49,365
+88
| +0.2% | +$3.46K |
|
502
Brown-Forman Class B
BF.B
$11.9B
| $1.87M | 0.03% |
62,022
-125
| -0.2% | -$3.66K |
|
503
Thermo Fisher Scientific
TMO
$214B
| $1.86M | 0.03% |
15,774
+580
| +4% | +$68.3K |
|
|
THI
504
DELISTED
TIM HORTONS INC COM, CANADA
THI
| $1.86M | 0.03% |
33,942
+525
| +2% | +$28.8K |
|
|
DSL
505
DoubleLine Income Solutions Fund
DSL
$1.22B
| $1.84M | 0.03% |
81,814
+32,114
| +65% | +$709K |
|
506
First Trust Large Cap Value AlphaDEX Fund
FTA
$1.36B
| $1.84M | 0.03% |
42,183
+4,466
| +12% | +$188K |
|
507
Energy Recovery
ERII
$439M
| $1.84M | 0.03% |
373,184
+93,150
| +33% | +$481K |
|
|
UQM
508
DELISTED
UQM Technologies, Inc.
UQM
| $1.83M | 0.03% |
806,777
+5,468
| +0.7% | +$12.1K |
|
|
DISCK
509
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $1.81M | 0.03% |
49,870
| – | – |
|
|
AGN
510
DELISTED
Allergan Inc
AGN
| $1.8M | 0.03% |
10,620
-22,908
| -68% | -$3.57M |
|
511
WisdomTree Japan Hedged Equity Fund
DXJ
$7.17B
| $1.79M | 0.03% |
36,231
+1,149
| +3% | +$54.4K |
|
512
Pediatrix Medical
MD
$2.09B
| $1.78M | 0.02% |
30,600
-949
| -3% | -$55.8K |
|
513
Exelon
EXC
$48B
| $1.77M | 0.02% |
67,937
-1,563
| -2% | -$39.9K |
|
514
Jazz Pharmaceuticals
JAZZ
$15.8B
| $1.76M | 0.02% |
+11,991
| New | +$1.66M |
|
515
CMS Energy
CMS
$22.9B
| $1.76M | 0.02% |
56,570
-7,948
| -12% | -$237K |
|
|
JPI
516
DELISTED
Nuveen Preferred Securities & Income Opportunities Fund
JPI
| $1.76M | 0.02% |
74,922
+62,752
| +516% | +$1.46M |
|
517
Golar LNG
GLNG
$5.09B
| $1.75M | 0.02% |
+29,090
| New | +$1.36M |
|
|
HERO
518
DELISTED
HERCULES OFFSHORE INC COM STK
HERO
| $1.75M | 0.02% |
434,191
+101,538
| +31% | +$453K |
|
519
American States Water
AWR
$3.42B
| $1.74M | 0.02% |
52,225
-640
| -1% | -$19.6K |
|
520
State Street Energy Select Sector SPDR ETF
XLE
$39.8B
| $1.74M | 0.02% |
34,674
+16,136
| +87% | +$764K |
|
521
Petrobras
PBR
$124B
| $1.73M | 0.02% |
+118,348
| New | +$1.72M |
|
522
AstraZeneca
AZN
$260B
| $1.72M | 0.02% |
23,152
-35,241
| -60% | -$2.55M |
|
523
Manitowoc
MTW
$501M
| $1.71M | 0.02% |
57,387
+31,590
| +122% | +$840K |
|
524
Vodafone
VOD
$35.6B
| $1.7M | 0.02% |
50,988
-68,812
| -57% | -$2.44M |
|
525
State Street Industrial Select Sector SPDR ETF
XLI
$33.8B
| $1.68M | 0.02% |
31,059
-335,912
| -92% | -$18M |
|
Similar funds
JCMLC
CIFMU
BPBT
RVP
ICM
FAAM
SAG
GIM
Baird's Q2 2014 Portfolio in Review
As of Q2 2014, Baird held 1,232 positions worth $7.13B, up 3.3% from $6.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Baird's Q2 2014 filing shows 125 new, 506 increased, 470 reduced and 92 closed positions. Its largest new stake was Globus Medical: 837,672 shares worth $20M. The largest sale was Toronto Dominion Bank, an estimated $42.2M.
By sector, the portfolio is most concentrated in Industrials at 13% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.
- Baird's largest Q2 2014 buy was Globus Medical: 837,672 shares worth $20M.
- Baird added most to International Paper in Q2 2014, an estimated $40.8M increase.
- Baird's biggest Q2 2014 reduction was Toronto Dominion Bank, cutting an estimated $42.2M.
- Baird fully exited Teradata in Q2 2014, selling an estimated $23.1M.
- Baird's ten largest holdings make up 13% of its $7.13B portfolio in Q2 2014.
- Baird opened 125 new positions and closed 92 in Q2 2014.
- Baird's portfolio value rose 3.3% quarter-over-quarter to $7.13B.
Based on Baird's 13F filing for Q2 2014, filed 8 Aug 2014.